Marc Damelin

2.8k citations

39 papers · 1.9k indexed · 1 hit paper · h-index 17

Impact in

Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- Nuclear Structure and Function
- RNA modifications and cancer

Papers in

Oncology 17
- HER2/EGFR in Cancer Research 10
Biotechnology 5
- Cancer Research and Treatments 5

Co-authors: Kenneth G. Geles Pamela A. Silver Bin‐Bing S. Zhou Peter B. Dirks Haiying Zhang Justin C. Grindley Timothy H. Bestor Wenyan Zhong
Journals: Cancer Research (8 papers)Molecular Cancer Therapeutics (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Cell (2 papers)Cold Spring Harbor Protocols (2 papers)
Partner nations: United States Canada Spain

In The Last Decade

Marc Damelin

38 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery 2009 · 687 citations

Peers

Countries citing papers authored by Marc Damelin

Since Specialization

Citations

This map shows the geographic impact of Marc Damelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Damelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Damelin more than expected).

Fields of papers citing papers by Marc Damelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Damelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Damelin. The network helps show where Marc Damelin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc Damelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Damelin Line = papers co-authored together Marc Damelin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates Molecular Cancer Therapeutics ·Joshua D. Thomas, M. Mantegazza, Mao Yin, Natalya D. Bodyak, Jephthah O. Osei, Marina Protopopova, B Rzegocinska-Tyzuk, Brian Jones, Liping Yang, Daniel Custar, Carlos González Baez, Damon R. Demady, Scott D. Collins, Ling Xu, A.L. Aspler, LiuLiang Qin, Elena Ter‐Ovanesyan, Marc Damelin, Dorin Toader, Timothy B. Lowinger	2024	0
2	Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses Nature Communications ·純一平野, Travis Monnell, Anette Iff, Pamela Shaw, R Lelandais, Carlos González Baez, Melissa Dolan, Rebecca Mosher, Mk., Chen‐Ni Chin, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Timothy B. Lowinger, Marc Damelin	2024	33
3	Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates Journal of Medicinal Chemistry ·Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid, Carlos González Baez, K. W. Bentley, Scott D. Collins, Timothy K. Eitas, Brian Jones, B Rzegocinska-Tyzuk, R Lelandais, Marina Protopopova, Soumya S. Ray, Elena Ter‐Ovanesyan, Ling Xu, Liping Yang, 掛見喜一郎, Marc Damelin, Dorin Toader, Timothy B. Lowinger	2023	32
4	Abstract 2114: Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells Cancer Research ·Naniye Mallı Cetinbas, Carlos González Baez, Travis Monnell, Anette Iff, K. W. Bentley, Susan M. Clardy, 김성준, 久雄伊藤, Marina Protopopova, Charles Dormoy, Joshua D. Thomas, Dea Levana, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	2022	6
5	620 Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates SHILAP Revista de lepidopterología ·Naniye Mallı Cetinbas, Travis Monnell, Winnie Lee, Carlos González Baez, Chen‐Ni Chin, Pamela Shaw, Kelly L. Slocum, LiuLiang Qin, Y. Liu, K. W. Bentley, Susan M. Clardy, Brian Jones, B Rzegocinska-Tyzuk, Joshua D. Thomas, Rebecca Mosher, Dorin Toader, Jeremy R. Duvall, Raghida A. Bukhalid, Marc Damelin, Timothy B. Lowinger	2020	3
6	A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA) Annals of Oncology ·Jasgit C. Sachdev, Michael L. Maitland, Monica Sharma, Víctor Moreno, Valentina Boni, Shivaani Kummar, Tarek Omran, Dawei Xuan, Tenshang Joh, Eric L. Powell, Amy Jackson-Fisher, Marc Damelin, Xiaohua Xin, Anthony W. Tolcher, Emiliano Calvo	2016	15
7	Breast Cancer Cells Respond Differentially to Modulation of TGFβ2 Signaling after Exposure to Chemotherapy or Hypoxia Cancer Research ·Abbey Kollar, Liang Chen, Wenyan Zhong, Douglas Armellino, Jiyang Yu, Christine Loreth, Maximillian T. Follettie, Marc Damelin	2015	9
8	Evolving Strategies for Target Selection for Antibody-Drug Conjugates Pharmaceutical Research ·Marc Damelin, Wenyan Zhong, Jeremy S. Myers, Puja Sapra	2015	110
9	Comprehensive Interrogation of a Minimalist Synthetic CDR-H3 Library and Its Ability to Generate Antibodies with Therapeutic Potential Journal of Molecular Biology ·Avram Kordon, Matthew Lambert, Jacob Glanville, H Khodayari Hajusefloo, Brian J. Fennell, Mark R.H. Krebs, Douglas Armellino, Sharon Yang, Xuemei Liu, Cliona O’Sullivan, R. Manera Escalero, K Pietrzak, Laird Bloom, Janet Paulsen, Davinder Gill, Marc Damelin, Orla Cunningham, William J.J. Finlay	2013	42
10	Long-term Tumor Regression Induced by an Antibody–Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells Molecular Cancer Therapeutics ·Puja Sapra, Marc Damelin, John F. DiJoseph, Kimberly Marquette, Kenneth G. Geles, Jonathon Golas, Maureen Dougher, H.A. Oostindië, Andreas Giannakou, Kiran Khandke, Russell G. Dushin, Elana Ernstoff, Judy Lucas, Mauricio Leal, Anita Khoerunnisa, Christopher J. O’Donnell, Lioudmila Tchistiakova, Robert T. Abraham, Hans‐Peter Gerber	2012	51
11	Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nature Reviews Drug Discovery ·Bin‐Bing S. Zhou, Haiying Zhang, Marc Damelin, Kenneth G. Geles, Justin C. Grindley, Peter B. Dirks Hit paper breakdown →	2009	687
12	Biological Functions of DNA Methyltransferase 1 Require Its Methyltransferase Activity Molecular and Cellular Biology ·Marc Damelin, Timothy H. Bestor	2007	56
13	The decatenation checkpoint British Journal of Cancer ·Marc Damelin, Timothy H. Bestor	2007	56
14	7 Inheritance of Genomic Methylation Patterns Cold Spring Harbor Monograph Archive ·Robert A. Rollins, Marc Damelin, Timothy H. Bestor	2006	2
15	Decatenation Checkpoint Deficiency Destabilizes the Stem Cell Genome Cell Cycle ·Marc Damelin, Timothy H. Bestor	2006	7
16	Decatenation checkpoint deficiency in stem and progenitor cells Cancer Cell ·Marc Damelin, Yi Eve Sun, M. Melon, Timothy H. Bestor	2005	61
17	In Situ Analysis of Spatial Relationships between Proteins of the Nuclear Pore Complex Biophysical Journal ·Marc Damelin, Pamela A. Silver	2002	20
18	The Genome-Wide Localization of Rsc9, a Component of the RSC Chromatin-Remodeling Complex, Changes in Response to Stress Molecular Cell ·Marc Damelin, Itamar Simon, Terence I. Moy, Boris G. Wilson, Suzanne Komili, Paul Tempst, Frederick P. Roth, Richard A. Young, Bradley R. Cairns, Pamela A. Silver	2002	120
19	Nuclear protein transport Methods in enzymology on CD-ROM/Methods in enzymology ·Marc Damelin, Pamela A. Silver, Anita H. Corbett	2002	33
20	Mapping Interactions between Nuclear Transport Factors in Living Cells Reveals Pathways through the Nuclear Pore Complex Molecular Cell ·Marc Damelin, Pamela A. Silver	2000	121

About Marc Damelin

Marc Damelin is a scholar working on Oncology, Biotechnology, Radiology, Nuclear Medicine and Imaging, Immunology and Cell Biology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (10 papers), interferon and immune responses (6 papers), Epigenetics and DNA Methylation (6 papers), RNA Research and Splicing (6 papers), Cancer Research and Treatments (5 papers), Neuroblastoma Research and Treatments (4 papers) and Biotin and Related Studies (4 papers). The work is most often cited by research in Oncology (738 citations), Molecular Biology (1.2k citations), Cancer Research (248 citations), Cell Biology (175 citations) and Radiology, Nuclear Medicine and Imaging (237 citations). Marc Damelin has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Kenneth G. Geles, Pamela A. Silver, Bin‐Bing S. Zhou, Peter B. Dirks, Haiying Zhang, Justin C. Grindley, Timothy H. Bestor, Wenyan Zhong, Anne O’Donnell‐Luria and Amos Tanay. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Proceedings of the National Academy of Sciences, Molecular Cell and Cold Spring Harbor Protocols.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact